Practice Management
No sooner do we close the books on one of the worst flu seasons in recent history than the Centers for Disease Control and Prevention tells us to expect a high volume of tick-, mosquito-, and flea-borne infections as the weather warms up. It’s not just greater numbers of the same diagnoses, either; new tickborne diseases like Heartland virus are showing up in the continental U.S. Tickborne diseases are climbing most in the Northeast, Upper …
Read More
Chronic pain patients who completed a comprehensive, multidisciplinary pain rehabilitation program used significantly fewer healthcare resources in a study presented at the American Academy of Pain Medicine’s 2018 annual meeting. The only exception was in behavioral health, in which access increased. Over the course of the 3-week program, patients with chronic (≥3 months) noncancer pain were able to access physical, occupational, and medical therapies and taper the doses of opioids prescribed to them. Researchers analyzed …
Read More
Updates to pain guidelines in the era of opioid addiction have focused on treatment of chronic pain, generally. The latest edict takes a close look at the practice of prescribing narcotic medications for acute pain, however—a subject all the more relevant to the urgent care provider. Improving the Safety of Opioid Use for Acute Noncancer Pain in Hospitalized Adults: A Consensus Statement from the Society of Hospital Medicine recommends limiting the use of opioids to …
Read More
A new report published online in the Centers for Disease Control and Prevention’s Vital Signs reveals that the CDC and health departments across the country identified more than 220 instances of germs with “unusual” antibiotic-resistant genes last year. Anne Schuchat, MD, principal deputy director of the CDC, called it “reassuring” that the resistant bacteria were identified because that’s the first step toward finding new ways to kill them. The report also notes that one in four germ …
Read More
The Centers for Disease Control and Prevention may have spoken too soon when it declared the 2017–2018 influenza season to be on the wane. Now the agency says cases are mounting—though right now it’s influenza B, not the H3N2, A strain that is both more severe and less receptive to vaccines. In fact, with the week ending March 17 influenza B has usurped influenza A as the most dominant strain of the moment. It’s not …
Read More
At least 85 patients known to have consumed kratom have been diagnosed with salmonellosis in 35 states since February 12, leading federal and state health officials to advise all individuals to stop taking kratom products. The FDA and several states have tested multiple kratom products; 25 were positive for Salmonella. Further testing is planned, according to the FDA. Kratom is used as an herbal drug in parts of Asia, and for self-medicating and recreationally in …
Read More
New data published in Pharmacoepidemiology & Drug Safety remind us about the dangers of pain medications—not opioids this time, but over-the-counter drugs like ibuprofen. After acetaminophen, it’s the second-most used drug in the U.S., and the most commonly used nonaspirin NSAID. Many patients are using excessive dosages, however, putting themselves at risk for dose-related side effects (eg, upper gastrointestinal bleeding and acute renal injury) that can be quite severe or even fatal. The P&DS research …
Read More
Over 1.8 million emergency room visits related to a diagnosis of eczema took place between 2006 and 2012, costing patients hours of waiting and their insurance providers millions of dollars. What’s more, the trend indicates the number will continue to rise. The question is, why? The likely answer—besides the fact that it takes forever to secure an appointment with a dermatologist—is that too many people are unfamiliar with the full capabilities of their closest urgent …
Read More
Though 45 states still report “widespread cases” of influenza, the total number of new cases in the United States is down for the second week in a row, leading the Centers for Disease Control and Prevention to declare that flu season has peaked. Only 5% of people visited providers complaining of flu symptoms last week, down from 6.4% the previous week. The agency cautioned that this does not mean it’s time to be less vigilant …
Read More
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) has recommended use of the FluMist Quadrivalent nasal spray influenza vaccine in the next influenza season. Starting 2 years ago, healthcare providers have been urged to not use that vaccine because the CDC said there was a lack of efficacy in preventing influenza. However, the new ACIP recommendation comes on the heals of a U.S. study in young children that found vaccines …
Read More